No, Trulicity is not indicated for type 1 diabetes or diabetic ketoacidosis and is not a substitute for insulin
This structural parallelism makes them excellent companion reference compounds in preclinical research because many physicochemical properties such as solubility, albumin binding, and subcutaneous depot behavior are comparable, isolating receptor pharmacology as the primary experimental variable
Due to potency, new users may wish to assess tolerance by consuming only 1/2 scoop
Fasting glucose, A1C, a complete lipid panel, liver enzymes, and a complete blood count provide the data needed to track how your body responds to the combination
Unlike crash diets where progress stalls, tirzepatide keeps working